top of page

Hepatoblastoma

Key points


Usually age <4y

2/3 Paediatric malignant Liver tumours

1:1,000,000

20% present with lung mets


Pathophysiology

Originates in hepatic stem cells

Increased risk in prematurity

Associated with Beckwith-Wiedemann Syndrome and Familial Adenomatous Polyposis


History and Examination

Ask about Hep B/C (may suggest hepatocellular carcinoma instead), family history of syndromes

Look for signs of hemihypertrophy/BWS


Investigations

May present on antenatal scan

Large echogenic to hypoechoic solid lesion, typically in the right lobe of the liver

Do foetal MRI


aFP - may need serial dilutions if very high. Need nomogram - 200,000 normal 1st day of life

May be low in some cases


A biopsy needle must never go through a normal sector, and ideally not a normal segment. If this is not possible, a laparoscopic biopsy must be taken


SIOPEL Pre-treatment extent of disease - PRETEXT staging


Liver divided in 4 segments based on Couinard


PRETEXT I: The tumour is confined to one section of the liver, three ADJOINING sections are free of tumour.

PRETEXT II: The tumour involves two adjacent sections of the liver, two ADJOINING sections are free of tumour.

PRETEXT III: The tumour involves three sections of the liver, with only one section being free of tumour.

PRETEXT IV: The tumour involves all four sections of the liver


Annotated with focality, extra-hepatic disease, mets, rupture, portal/IVC involvement


POSTEXT - stage after procedure


Additional important features to view on MRI Abdomen aside from tumour and PRETEXT stage

  • Lymphatic involvement

  • Venous involvement

  • Hilar involvement (may require transplant)



Histological Patterns

  • Hepatoblastoma mirrors liver development stages

  • Combination of patterns: foetal, embryonal, macrotrabecular, small cell undifferentiated, cholangioblastic, stromal derivatives, teratoid

  • 20% of tumours include stromal derivatives like osteoid, chondroid, rhabdoid elements

  • Occasionally includes neuronal, melanocytic, squamous, and enteroendocrine elements


Two histological types impact prognosis:

  • Well differentiated foetal (WDF) cells resemble foetal hepatocytes with minimal mitotic activity and can be treated safely with surgery alone without chemotherapy

  • Small cell undifferentiated (SCU) primitive cells show neither epithelial nor stromal differentiation and have a worse prognosis



Anatomy

Liver Couinaud segments


The liver is split by the middle hepatic vein, creating a vertical plane that extends from the inferior vena cava to the fossa of the gallbladder. This division is referred to as Cantlie's line


Horizontal plane is at point of portal vein bifurcation

Segment 1 is caudate lobe

Segments 2-8 go clockwise from upper left lobe


Middle and left hepatic veins form common trunk in 85-95%


Bile ducts

Anterior + posterior right ducts - form main right duct

Left ducts from segments 2 + 3, duct from segment 4 joins to form left duct


Complications

Ototoxicity from cisplatin

Cardiotoxicity from Doxorubicin


Outcome

Based on stage, histology, metastases and aFP at diagnosis

Low aFP poor prognosis

90-100% 5y Survival low risk

20-60% 5y Survival High risk


Standard scenario


Concern is malignancy - hepatoblastoma


Ensure stabilised by oncology team


History:

Onset of symptoms

Nutrition and feeding

Family history of FAP etc


Examination:

Mass

Stigmata of hepatic failure

Signs of BWS


Investigations:

aFP + nomogram

USS


MRI abdomen -

Sector involvement + PRETEXT

Hilar involvement - may need transplant

Relationship to vessels

Lymph nodes

Extra-hepatic disease


CT chest for staging


PRETEXT 1-3 no mets = Standard risk

4 or mets = High risk


Oncology MDT


Biopsy + Hickman line

Needle should NOT go through normal sector and ideally not normal segment


Refer to Liver MDT


Management

Enrol in trial or:

SIOPEL 6 - Standard risk - 6 cycles cisplatin monotherapy with surgery after 4th (4 weeks)

SIOPEL 4 - High risk - weekly cisplatin, doxorubicin every 3 weeks, total 8 cycles - surgery after 3 dox doses (9 weeks)


POSTEXT staging after chemo


Surgery:

Mobilise liver

Sling infra and supra hepatic IVC to prevent air emboli and control bleeding

Sling portal triad

Use USS to look at tumour extent and vascular supply

Divide arteries and veins to segments, will demarcate, divide parenchyma

No need to resect gallbladder

Need full resection with clear margins

Hemihepatectomy for POSTEXT 1-3

POSTEXT 3 may need major venous resection or transplant

POSTEXT 4 - Transplant

Extended lobectomy (trisegmentectomy) - leave behind either 2+3 on left or 6+7 on right

Resect lung mets if not responded to chemo - controversial timing - some advocate for pre liver resection


Resume chemo 3 weeks after surgery to allow healing


References


CCLG: Treatment guidelines for hepatoblastoma (including recurrent disease)

February 2020 (updated in accordance with PHITT)


Meyers, Rebecka L. "Hepatoblastoma." Pediatric Surgery NaT, American Pediatric Surgical Association, 2023. Pediatric Surgery Library, www.pedsurglibrary.com/apsa/view/Pediatric-Surgery-NaT/829121/all/Hepatoblastoma.


Jones J, Campos A, Hirano Y, et al. Couinaud classification of hepatic segments. Reference article, Radiopaedia.org (Accessed on 20 Jul 2024) https://doi.org/10.53347/rID-4474

Previous
topic

Next 
topic

Back to topic home

© 2025 by EncycloPaediatric Surgery, an ON:IX production

Please note that all information on this site is for professional educational purposes only, it does not constitute medical advice

bottom of page